InvestorsObserver is giving NLS Pharmaceutics AG (NLSP) an Analyst Rating Rank of 74, meaning NLSP is ranked higher by analysts than 74% of stocks. The average price target for NLSP is $10 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating NLSP a Strong Buy today. Find out what this means to you and get the rest of the rankings on NLSP!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With NLS Pharmaceutics AG Stock Today?
NLS Pharmaceutics AG (NLSP) stock is up 2.86% while the S&P 500 is down -0.05% as of 11:48 AM on Wednesday, Nov 24. NLSP is up $0.05 from the previous closing price of $1.75 on volume of 180,752 shares. Over the past year the S&P 500 is up 26.22% while NLSP is down -37.72%. NLSP lost -$0.55 per share the over the last 12 months.
Click Here to get the full Stock Report for NLS Pharmaceutics AG stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
